Major study launches to track 1,000 breast cancer patients
NCT ID NCT06603597
Summary
This study aims to better understand what factors influence survival and treatment success for people with HER2-positive breast cancer. Researchers will follow 1,000 patients with different stages of the disease for five years. The goal is to collect information that may help improve future care by identifying which patient or tumor characteristics lead to the best outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2 + BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
KUCC - Briarcliff
ACTIVE_NOT_RECRUITINGWestwood, Kansas, 66205, United States
-
KUCC - Indian Creek
ACTIVE_NOT_RECRUITINGOverland Park, Kansas, 66211, United States
-
KUCC - Lee's Summit
ACTIVE_NOT_RECRUITINGLee's Summit, Missouri, 64064, United States
-
KUCC - Olathe
ACTIVE_NOT_RECRUITINGWestwood, Kansas, 66205, United States
-
KUCC - Overland Park
ACTIVE_NOT_RECRUITINGOverland Park, Kansas, 66215, United States
-
The University of Kansas Cancer Center
RECRUITINGWestwood, Kansas, 66205, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.